Grant Details
Grant Number: |
5U24CA221936-06 Interpret this number |
Primary Investigator: |
Li, Christopher |
Organization: |
Fred Hutchinson Cancer Center |
Project Title: |
Coordinating Center for Population-Based Research to Optimize Cancer Screening (PROSPR) (U24) |
Fiscal Year: |
2023 |
Abstract
Project Summary
Cancer screening is a complex, multi-step process where benefits are maximized when each step is completed
successfully, but where sub-optimal outcomes are frequent as a result of breakdowns that can happen at any
point in this process. Screening is also impacted by factors beyond simply individual patients—including factors
at the provider-, practice-, and health plan/institution-level—and these so-called systems level factors can
impact the appropriate delivery of high quality cancer screening services. PROSPR was established to address
a number of critical questions related to the delivery of cancer screening in the United States, and our
PROSPR I Statistical Coordinating Center was central to many of the successes of this initiative including: 1)
Developing a trans-organ conceptual model of cancer screening processes, 2) Creating common data
elements and screening performance metrics, 3) Evaluating individual and systems-level factors impacting
screening performance, 4) Authorship and statistical support on 21 trans-network published papers, 2 under
review, and 17 in preparation; and 5) Establishing PROSPR data repositories and creating an infrastructure for
publicly sharing PROSPR data. Our PCC team has considerable expertise both in the leadership of large
coordinating centers and in each of the scientific fields relevant to PROSPR including health services/health
care delivery, implementation science, cancer epidemiology, health disparities research, biostatistics,
bioinformatics/health information technology, and the screening of colorectal, cervical, and lung cancers. Thus,
we are uniquely positioned to successfully execute all components of this coordinating center. The specific
aims of our PCC are to: 1) Provide administrative coordination for the PROSPR network and guidance in the
development of PROSPR’s governance, organization, and policies/procedures; 2) Lead the development of
common conceptualization and measures for: A. Assessing the role of systems-level factors that impact the
screening process. B. Assessing screening quality; 3) Facilitate trans-PROSPR research comparing the
screening process across at least 2 organ sites; and 4) Develop and implement processes and procedures to
share PROSPR data with qualified investigators outside of the PROSPR network. RELEVANCE: Improving
both the screening process and screening quality for cervical, colorectal, and lung cancers will reduce
mortality, morbidity, and health care costs associated with these cancers in the United States.
Publications
Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems.
Authors: Issaka R.B.
, Ibekwe L.N.
, Todd K.W.
, Burnett-Hartman A.N.
, Clark C.R.
, Del Vecchio N.J.
, Kamineni A.
, Neslund-Dudas C.
, Chubak J.
, Corley D.A.
, et al.
.
Source: Cancer, 2024-08-09 00:00:00.0; , .
EPub date: 2024-08-09 00:00:00.0.
PMID: 39119731
Related Citations
Data gaps and opportunities for modeling cancer health equity.
Authors: Trentham-Dietz A.
, Corley D.A.
, Del Vecchio N.J.
, Greenlee R.T.
, Haas J.S.
, Hubbard R.A.
, Hughes A.E.
, Kim J.J.
, Kobrin S.
, Li C.I.
, et al.
.
Source: Journal Of The National Cancer Institute. Monographs, 2023-11-08 00:00:00.0; 2023(62), p. 246-254.
PMID: 37947335
Related Citations
Provider- and Facility-Level Variation in Pre-Cancerous Cervical Biopsy Diagnoses.
Authors: Del Vecchio N.J.
, Beaber E.F.
, Garcia M.P.
, Wheeler C.M.
, Kamineni A.
, Chao C.
, Chubak J.
, Corley D.A.
, Owens C.L.
, Winer R.L.
, et al.
.
Source: Journal Of Lower Genital Tract Disease, 2023-01-17 00:00:00.0; , .
EPub date: 2023-01-17 00:00:00.0.
PMID: 36728078
Related Citations
Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines.
Authors: Kamineni A.
, Doria-Rose V.P.
, Chubak J.
, Inadomi J.M.
, Corley D.A.
, Haas J.S.
, Kobrin S.C.
, Winer R.L.
, Elston Lafata J.
, Beaber E.F.
, et al.
.
Source: Annals Of Internal Medicine, 2022 Nov; 175(11), p. 1582-1590.
EPub date: 2022-09-27 00:00:00.0.
PMID: 36162112
Related Citations
Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval.
Authors: Chubak J.
, Burnett-Hartman A.N.
, Barlow W.E.
, Corley D.A.
, Croswell J.M.
, Neslund-Dudas C.
, Vachani A.
, Silver M.I.
, Tiro J.A.
, Kamineni A.
.
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2022-08-02 00:00:00.0; 31(8), p. 1517-1520.
PMID: 35916602
Related Citations
Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.
Authors: Beaber E.F.
, Kamineni A.
, Burnett-Hartman A.N.
, Hixon B.
, Kobrin S.C.
, Li C.I.
, Oliver M.
, Rendle K.A.
, Skinner C.S.
, Todd K.
, et al.
.
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2022-08-02 00:00:00.0; 31(8), p. 1521-1531.
PMID: 35916603
Related Citations
De-implementation of cervical cancer screening before age 21.
Authors: Silver M.I.
, Anderson M.L.
, Beaber E.F.
, Haas J.S.
, Kobrin S.
, Pocobelli G.
, Skinner C.S.
, Tiro J.A.
, Kamineni A.
.
Source: Preventive Medicine, 2021 Dec; 153, p. 106815.
EPub date: 2021-09-29 00:00:00.0.
PMID: 34599920
Related Citations
Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.
Authors: Croswell J.M.
, Corley D.A.
, Lafata J.E.
, Haas J.S.
, Inadomi J.M.
, Kamineni A.
, Ritzwoller D.P.
, Vachani A.
, Zheng Y.
, National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) II Consortium
.
Source: Preventive Medicine, 2021 10; 151, p. 106595.
EPub date: 2021-06-30 00:00:00.0.
PMID: 34217414
Related Citations
An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer.
Authors: Burnett-Hartman A.N.
, Lee J.K.
, Demb J.
, Gupta S.
.
Source: Gastroenterology, 2021-01-05 00:00:00.0; , .
EPub date: 2021-01-05 00:00:00.0.
PMID: 33417940
Related Citations
Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium.
Authors: National Cancer Institute’s PROSPR Consortium
, Corley D.A.
, Sedki M.
, Ritzwoller D.P.
, Greenlee R.T.
, Neslund-Dudas C.
, Rendle K.A.
, Honda S.A.
, Schottinger J.E.
, Udaltsova N.
, et al.
.
Source: Gastroenterology, 2020-10-21 00:00:00.0; , .
EPub date: 2020-10-21 00:00:00.0.
PMID: 33096099
Related Citations
ANALYSES OF PREVENTIVE CARE MEASURES WITH INCOMPLETE HISTORICAL DATA IN ELECTRONIC MEDICAL RECORDS: AN EXAMPLE FROM COLORECTAL CANCER SCREENING.
Authors: Zheng Y.
, Corley D.A.
, Doubeni C.
, Halm E.
, Shortreed S.M.
, Barlow W.E.
, Zauber A.
, Tosteson T.D.
, Chubak J.
.
Source: The Annals Of Applied Statistics, 2020 Jun; 14(2), p. 1030-1044.
EPub date: 2020-06-29 00:00:00.0.
PMID: 34531936
Related Citations
Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.
Authors: Rendle K.A.
, Burnett-Hartman A.N.
, Neslund-Dudas C.
, Greenlee R.T.
, Honda S.
, Elston Lafata J.
, Marcus P.M.
, Cooley M.E.
, Vachani A.
, Meza R.
, et al.
.
Source: Cancer Prevention Research (philadelphia, Pa.), 2019-12-23 00:00:00.0; , .
EPub date: 2019-12-23 00:00:00.0.
PMID: 31871221
Related Citations